Navigation Links
Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.
Date:8/19/2013

the United States and Asia. Janssen Research & Development is leveraging a combination of internal and external innovation to discover and develop novel medicines and solutions in five distinct therapeutic areas:  Neuroscience, Oncology, Immunology, Infectious Diseases and Vaccines, and Cardiovascular and Metabolism. For more information about Janssen Research & Development, LLC, visit www.janssenrnd.com.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Janssen Research & Development, LLC and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest rate and currency exchange rate fluctuations; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; challenges to patents; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to governmental laws and regulations and domestic and foreign health care reforms; trends toward health care cost containment; and increased scrutiny of the health care industry by government agencies. In addition, there will be risks and uncertainties related to the ability of Janssen Research & Development, LLC and/or Johnson & Johnson to successfully integrate the business of Aragon Pharmaceuticals, Inc. A further list and description of these risks, uncertainties and oth
'/>"/>

SOURCE Johnson & Johnson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
2. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
3. N.J. Woman Sues Johnson & Johnsons Ethicon Unit Over Vaginal Mesh Injuries, Says The Lanier Law Firm
4. Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results
5. GHX CEO Bruce Johnson Recognized as Ernst & Young Rocky Mountain Region Entrepreneur of the Year 2012
6. Johnson & Johnson Provides Notice Of Proposed Settlement Of Shareholder Derivative Actions, Final Settlement Hearing, And Right To Appear
7. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
8. EFJohnson Announces Impact Partner Dealer Program
9. Johnson Health Tech Statement on Lance Armstrong
10. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
11. Johnson & Johnson Announces Plans to Establish Innovation Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... N.C. , March 31, 2015  Dr. Renu ... be attending the World Orphan Drug Congress in April to ... regulatory approval process and orphan drugs below: ... has recommended to the Ministry of Health that if a ... marketing authorization can be obtained in India ...
(Date:3/31/2015)...  On May 2, 2015 global experts on ... Santa Monica, CA at the 5th ... Pleural Mesothelioma (MPM), a rare form of cancer ... affects the lining of the chest– the pleura. ... Pacific Mesothelioma Center (PMC). ...
(Date:3/31/2015)... , March 31, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ... developing premium quality medical marijuana products and a licensed ... Medical Purposes Regulations ( Canada ) ("MMPR"), ... from The Corporation of the District of ... the Company,s premises which now allows for commercial distribution ...
Breaking Medicine Technology:Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3
... YORK, Nov. 15, 2011 ... market research report is available ... Bristol-Myers Squibb: Performance, Capabilities, ... Worldwide Pharmaceutical Market ...
... Idaho, Nov. 15, 2011 International Isotopes Inc. ... for the third quarter and nine-months ended September 30, 2011. ... 30, 2011 was $2,229,947, as compared to $1,783,047 for the ... approximately 25%.  Revenue for the nine-month period ended September 30, ...
Cached Medicine Technology:Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market 2Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market 3International Isotopes Inc. Announces Third Quarter and Nine Months 2011 Financial Results 2International Isotopes Inc. Announces Third Quarter and Nine Months 2011 Financial Results 3International Isotopes Inc. Announces Third Quarter and Nine Months 2011 Financial Results 4International Isotopes Inc. Announces Third Quarter and Nine Months 2011 Financial Results 5International Isotopes Inc. Announces Third Quarter and Nine Months 2011 Financial Results 6International Isotopes Inc. Announces Third Quarter and Nine Months 2011 Financial Results 7International Isotopes Inc. Announces Third Quarter and Nine Months 2011 Financial Results 8
(Date:3/31/2015)... 2015 For bariatric health professionals who ... return on their investment, Rice Lake Weighing Systems ... Medicine 2015, April 8-12 at the Colorado Convention Center ... and medical offices, Rice Lake’s BCA uses the most ... Obesity Medicine 2015 delivers clinical and practical knowledge about ...
(Date:3/31/2015)... The Heart Fit Clinic now ... surrounding areas. External Counterpulsation is an amazing evidence-based ... specifically stable coronary artery disease. External Counterpulsation ... extensively all over the world for the treatment ... are extremely fortunate to have the treatment here. ...
(Date:3/31/2015)... My Positive Perspective host Jason Deierlein was joined by On ... Man event. At the start of the episode, Deierlein asked ... replies, “The Month of Man is actually a 31 day ... storming. At the corner stone is eleven different events and ... baseball pitching and sunflower seed spitting and dizzy bat racing. ...
(Date:3/31/2015)... Spring Hill, FL (PRWEB) March 31, 2015 ... and Substance Abuse (CASA) at Columbia University states that ... arrested in the U.S. and enter state juvenile justice ... abuse problems, are under the influence of drugs or ... of these factors. Despite this high incidence of substance-related ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Diane ... Education at the Mesothelioma Applied Research Foundation (Meso ... “Asbestos and Your Health” at the BoRit Asbestos ... this April. This program will discuss anatomy, six ... environment, asbestos diseases, symptoms, treatments, prevention and proper ...
Breaking Medicine News(10 mins):Health News:Rice Lake Weighing Systems’ Body Composition Analyzer On Display at Obesity Medicine 2015 2Health News:New Heart Disease Treatment Called External Counterpulsation (EECP) helps people of Alberta Who Have Failed or Are Not Suitable For Heart Stents or Surgery 2Health News:My Positive Perspective Releases Episode Discussing the Month of Man Event 2Health News:$14.4 Billion Annual Price Tag: Suncoast Rehab Center Questions Harsh Sentencing of Juvenile Drug and Alcohol Offenders 2Health News:$14.4 Billion Annual Price Tag: Suncoast Rehab Center Questions Harsh Sentencing of Juvenile Drug and Alcohol Offenders 3Health News:$14.4 Billion Annual Price Tag: Suncoast Rehab Center Questions Harsh Sentencing of Juvenile Drug and Alcohol Offenders 4Health News:Mesothelioma Foundation to speak at BoRit Asbestos Superfund Citizen Advisory Group Meeting 2
... AMA President, Dr Mukesh Haikerwal, today called for a calm and ... the wake// of the deaths at Broughton Hall in Melbourne. ... a tragedy, but the AMA believes it is not a time ... ,'It is a time to carefully identify the causes for ...
... Mukesh Haikerwal today called on the Federal Government to ... after a new study revealed// that two-thirds of advertising ... ,'This startling study demonstrates that junk food ... young people,' Dr Haikerwal said. ,'Children ...
... food imported into the United States is actually inspected. Further, ... or the other. What happens to the rest of the ... States has been reeling under the effect of contaminated food, ... be due to lenient food laws in the countries from ...
... California – A kind of Omega-3 fatty acid called DHA, ... supplements assists in delaying// the arrival of Alzheimer's disease. ... on mice to investigate the effects of DHA; they found ... amyloid, which comes together to form plaques in the brain. ...
... concerted action to ensure that people who are at risk ... according to the authors of a new report published today ... shows that influenza epidemics are associated with a rise in ... the heart attacks that result in death. ,However, ...
... the miss, is Texas A&M University. The university has made ... This change is expected to be felt or rather, consumed ... at campus facilities, which range from cafeteria-style dining halls, restaurants ... , Yet, this is not the end of the ...
Cached Medicine News:Health News:AMA Calls For Calm Approach To Aged Care Illness Outbreaks 2Health News:New Research Shows That Flu is a Trigger of Heart Attacks 2Health News:New Research Shows That Flu is a Trigger of Heart Attacks 3Health News:New Research Shows That Flu is a Trigger of Heart Attacks 4
View Mex-2 is designed for out-patient surgery, hospital rounds and house calls....
It provides excellent illumination from an inexpensive platform and is mounted on the comfortable UltraLite headband....
Headlight module is mounted on UltraLite Plus headband....
... rapid rise in intracranial ... intervention and continuous monitoring. ... technology that gets to ... Its versatility makes it ...
Medicine Products: